Clinical updates, including trial initiations, enrollment status and data readouts and publications: Preludedx.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: 4D Molecular, Actinium, Avidity, Inmagene, Kiora, Nanoscope, Olix, Ovid, Takeda, Tempest.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Xeltis.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Alligator, Alnylam, Amphera, Avacta, Biocryst, Bionomics, Celularity, Cinrx, Clearside, Elicio, Galapagos, Junshi, Lilly, Minoryx, Nexcella, Palatin, Regeneron, Skye.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: CND Life Sciences, Lumicell, Micronoma.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Alentis, Allovir, Avenge, Belite, Biomind, Bloom, Calico, Contrafect, Evelo, Impel, Inhibikase, Inhibrx, Kancera, Kiora, Lianbio, Lineage, Novartis, Otsuka, Prilenia, Roche, SAB, Sunovion.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Amo, Aphaia, Arrowhead, Artelo, Atsena, Baudax, Erasca, First Wave, Hillevax, Lyra, Morphic, Okyo, Omeros, Parthenon, Samsung, Trefoil, Ultimovacs, Vaccinex.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Arch, Axcella, Beigene, Cantex, Gritstone, Immutep, Junshi, Relief, Shionogi.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Castle Biosciences, Moleculight, Myocene.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Apellis, Applied, Astrazeneca, Belief, Citius, Daewoong, Faron, Foghorn, Ideaya, I-Mab, In8bio, Ionis, Krystal, Medigene, Neurona, Newamsterdam, Oncoinvent, Pharma Two B, Unity.